Effect of Reminiscence Therapy on Elderly Well-Being
Psychological Well-Being and Mindfulness in the Elderly: The Effect of Reminiscence Therapy
This study tests if reminiscence therapy can improve the mental well-being of older adults aged 65 and up.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 65 Years to 100 Years |
| Sex | All |
| Sponsor | Muş Alparslan University Academic / other |
| Locations | 1 site (Elâzığ) |
| Trial ID | NCT06964399 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of reminiscence therapy on the psychological well-being and awareness levels of elderly individuals. Participants aged 65 and older will be randomly assigned to either an experimental group receiving reminiscence therapy or a control group with no intervention. After obtaining consent, participants will complete pre- and post-therapy assessments to evaluate changes in their psychological state. The goal is to explore non-pharmacological interventions that can enhance the quality of life for the aging population.
Who should consider this trial
Good fit: Ideal candidates for this study are elderly individuals over 65 years old without serious psychiatric disorders or dementia.
Not a fit: Patients with serious psychiatric disorders or those unable to attend therapy sessions will not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly improve the mental health and quality of life for elderly patients experiencing cognitive decline.
How similar studies have performed: Previous studies have shown positive outcomes with reminiscence therapy in improving psychological well-being among elderly populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being over 65 years old * not having any serious psychiatric disorders * not having any diseases such as dementia etc. Exclusion Criteria: * Having a serious psychiatric disorder * Not being able to attend sessions during the research process
Where this trial is running
Elâzığ
- Ağın Community Health Center — Elâzığ, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Güzel Nur YILDIZ, Dr — Muş Alparslan University
- Study coordinator: Meltem ÇAPAR, Specialist
- Email: sevdai_naram@hotmail.com
- Phone: 534 870 67 49
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.